INmune Bio
INMB
INMB
36 hedge funds and large institutions have $17.4M invested in INmune Bio in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.64% less ownership
Funds ownership: 12.86% → 11.23% (-1.6%)
9% less capital invested
Capital invested by funds: $19.1M → $17.4M (-$1.72M)
Holders
36
Holding in Top 10
–
Calls
$645K
Puts
$413K
Top Buyers
| 1 | +$239K | |
| 2 | +$164K | |
| 3 | +$112K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$79.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$70.8K |
Top Sellers
| 1 | -$686K | |
| 2 | -$568K | |
| 3 | -$521K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$387K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$368K |